Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Indicators identify shingles patients who have an increased risk of developing persistent pain

Researchers have recently confirmed a set of indicators that, alone and in combination, identify shingles patients who have an increased risk of developing persistent pain after the shingles rash heals. Results and implications of their study will be presented in the May 11 issue of Neurology, the scientific journal of the American Academy of Neurology.

10 May 2004

Ritalin drug used to treat hyperactive children boosts the potency of Parkinson's drug levodopa

A well-known drug used to treat hyperactive children boosts the potency of another drug that reduces Parkinson's disease symptoms, an Oregon Health & Science University study has found.

6 May 2004

Mylan announces FDA approval of Parkinson’s disease drug

The FDA approval clears the way for Bertek to market APOKYN and provides a new therapy for “off” episodes, one of the most debilitating aspects suffered by patients with Parkinson’s disease.

5 May 2004

Tooth cells may help treat Parkinson's disease

Cells derived from the inside of a tooth might someday prove an effective way to treat the brains of people suffering from Parkinson's disease.

4 May 2004

Transplanted bone-marrow cells could regenerate nerve cells in the brain

Findings of a preliminary study in this week's issue of THE LANCET suggest that transplanted adult bone-marrow cells could regenerate nerve cells in the brains of human stem-cell recipients. These early findings, if confirmed in future research, have implications for the treatment of neurodegenerative disorders such as Parkinson's disease.

29 Apr 2004

Antiepileptic drug Levetiracetam may help patients with Parkinson's disease

In patients with Parkinson's disease, the antiepileptic drug levetiracetam (Keppra(R)) reduced the involuntary movements (dyskinesia) associated with levodopa, the medication most commonly used to treat Parkinson's disease, according to a study presented today at the 56th annual meeting of the American Academy of Neurology.

29 Apr 2004

Greater severity of depressive symptoms correlates with increased risk of stroke among whites

Greater severity of depressive symptoms correlates with increased risk of stroke among whites, according to research that will be presented at the American Academy of Neurology 56th Annual Meeting in San Francisco, Calif., April 24 – May 1, 2004.

28 Apr 2004

PET imaging has recently been shown to aid in the diagnosis of particular neurological syndromes associated with cancer

PET imaging has been shown to improve detection of a variety of cancers, and earlier tests have suggested this technique may be useful in identifying small tumors in patients with paraneoplastic neurological disorders. But PET imaging is not yet widely available, and clear indicators of clinically meaningful outcomes using PET are essential to warrant use with this patient population.

28 Apr 2004

A popular supplement, coenzyme Q10 (CoQ10), may help prevent migraine

Migraine patients who took 100 mg three times a day of CoQ10—which acts as the body’s energy producer—had fewer attacks in three months than those who took a placebo. The participants taking CoQ10 also had fewer days with a headache and fewer days with nausea.

28 Apr 2004

Results look promising in Alzheimer’s gene therapy trial

Surgical placement of genetically modified tissue directly into the brains of patients with Alzheimer’s disease, an experimental approach to delaying brain cell loss associated with the disease, leads to increased metabolic activity in the brain, with cells apparently responding to the insertion of growth factor-producing grafts

28 Apr 2004

Study shows MIRAPEX(R) (pramipexole) relieves patients with restless legs syndrome

Results from a large-scale, randomized, double-blind study show MIRAPEX(R) (pramipexole) provides rapid relief in patients with restless legs syndrome (RLS).

28 Apr 2004

New teatment for intractable low blood pressure

Patients are generally pleased with a new Mayo Clinic drug treatment for a common form of impaired nerve transmission that causes dizziness and fainting when patients change position from lying down to standing up, and most want to continue using it.

28 Apr 2004

Blood pressure drug helps delay ischemic brain damage in stroke patients

A drug used to lower blood pressure can help stop or delay the progress of further ischemic brain lesions in stroke patients according to research that will be presented at the American Academy of Neurology 56th Annual Meeting in San Francisco, Calif., April 24 – May 1, 2004.

27 Apr 2004

Apolipoprotein E (APOE) gene may increase the risk of Parkinson’s disease

One variant of the apolipoprotein E (APOE) gene may increase the risk of Parkinson’s disease, according to an analysis of research that will be presented at the American Academy of Neurology 56th Annual Meeting in San Francisco, Calif., April 24 – May 1, 2004.

27 Apr 2004

Improvement of Parkinson’s disease symptoms when neurorestorative molecule pumped to the center of the brain

A recent study has shown clinical improvement of Parkinson’s disease symptoms after long-term infusion of a neurorestorative molecule, pumped directly to the center of the brain. The study will be presented at the American Academy of Neurology 56th Annual Meeting in San Francisco, Calif., April 24 – May 1, 2004.

27 Apr 2004

Researchers show that language “center” of brain shifts with age

Along with left- or right-handedness, the hemisphere of the brain where language capacity resides is likely predetermined. Researchers have now shown that with age, language capacity in the brain becomes more evenly distributed between hemispheres.

27 Apr 2004

The muscle supplement creatine is safe, but not effective, in pediatric neuromuscular disease

The muscle supplement creatine can be safely taken by children with neuromuscular diseases, but does not improve strength or muscle mass, according to research that will be presented at the American Academy of Neurology 56th Annual Meeting in San Francisco, Calif., April 24 – May 1, 2004.

27 Apr 2004

Women who have migraines with aura have a more than 50 percent increased risk of total stroke and 70 percent increase of ischemic stroke

Women who have migraines with aura have a more than 50 percent increased risk of total stroke and 70 percent increase of ischemic stroke compared to those without migraines, according to research that will be presented at the American Academy of Neurology 56th Annual Meeting

27 Apr 2004

Parkinson’s disease drug Pergolide effective in treating restless legs syndrome

Pergolide, a drug commonly used to treat Parkinson’s disease symptoms, has recently been shown to be effective in treating restless legs syndrome. Researchers from seven countries collaborated on the study, published in the April 27 issue of Neurology, the scientific journal of the American Academy of Neurology.

26 Apr 2004

Alzheimer’s drug has been shown to improve memory and cognition in multiple sclerosis (MS) patients

A drug widely used for treating dementia in Alzheimer’s patients has been shown to improve memory and cognition in multiple sclerosis (MS) patients who are mild to moderately cognitively impaired.

26 Apr 2004

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Indicators identify shingles patients who have an increased risk of developing persistent pain

Ritalin drug used to treat hyperactive children boosts the potency of Parkinson's drug levodopa

Mylan announces FDA approval of Parkinson’s disease drug

Tooth cells may help treat Parkinson's disease

Transplanted bone-marrow cells could regenerate nerve cells in the brain

Antiepileptic drug Levetiracetam may help patients with Parkinson's disease

Greater severity of depressive symptoms correlates with increased risk of stroke among whites

PET imaging has recently been shown to aid in the diagnosis of particular neurological syndromes associated with cancer

A popular supplement, coenzyme Q10 (CoQ10), may help prevent migraine

Results look promising in Alzheimer’s gene therapy trial

Study shows MIRAPEX(R) (pramipexole) relieves patients with restless legs syndrome

New teatment for intractable low blood pressure

Blood pressure drug helps delay ischemic brain damage in stroke patients

Apolipoprotein E (APOE) gene may increase the risk of Parkinson’s disease

Improvement of Parkinson’s disease symptoms when neurorestorative molecule pumped to the center of the brain

Researchers show that language “center” of brain shifts with age

The muscle supplement creatine is safe, but not effective, in pediatric neuromuscular disease

Women who have migraines with aura have a more than 50 percent increased risk of total stroke and 70 percent increase of ischemic stroke

Parkinson’s disease drug Pergolide effective in treating restless legs syndrome

Alzheimer’s drug has been shown to improve memory and cognition in multiple sclerosis (MS) patients

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in